The 20 Best Pseudomyxoma Peritonei Doctors Near Me in Ann Arbor, MI

Dr. Michael McGee is Clinical Associate Professor of Surgery and Chief of the Division of Colorectal Surgery at the University of Michigan. Prior to obtaining his medical degree at Drexel University, he was trained as a mechanical engineer. After completing general surgery training at Case Western Reserve University, Dr. McGee completed colorectal surgery fellowship at Cleveland Clinic. While at Case Western, Dr. McGee completed the Dudley P. Allen Scholarship dedicated to clinical research in minimally invasive surgery and surgical endoscopy. Dr. McGee was recruited to Northwestern University where he practiced for 11 years and held several system-wide administrative roles for Northwestern Medicine before joining the University of Michigan in 2022. Dr. McGee’s clinical interests include complex re-operative abdominal surgery, minimally invasive colorectal surgery, surgical endoscopy, and anorectal surgery for cancer and inflammatory bowel disease. He served as co-director of the 50+ hospital Illinois Surgical Quality Improvement Collaborative (ISQIC) where he led day-to-day operations and statewide quality improvement projects for thousands of surgical patients in Illinois. Dr. McGee’s research interests include surgical quality improvement, implementation science, and patient education. He is an active member of several national surgical organizations, multiple editorial boards, and has authored over fifty publications and received multiple grants and awards for research, teaching, and humanism. Dr. Mcgee is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Gastrointestinal Fistula, Colostomy, and Hernia Surgery. Dr. Mcgee is board certified in Surgery and Colon & Rectal Surgery.

Scott Regenbogen, MD, MPH is a Professor of Surgery and Division Chief of Colorectal Surgery. He graduated from Princeton University with an A.B. in psychology, and received his M.D. degree from the University of California, San Francisco. He completed General Surgery residency at the Massachusetts General Hospital, including three years as a Postdoctoral Fellow in Health Services Research, and was awarded a Master’s in Public Health from the Harvard School of Public Health. He then completed fellowship training in Colon and Rectal Surgery at the Lahey Clinic, and joined the faculty of the University of Michigan in 2011.Clinical SpecializationDr. Regenbogen's clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. He has a particular interest in the use of laparoscopic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Regenbogen is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Hernia Surgery. Dr. Regenbogen is board certified in Surgery and Colon & Rectal Surgery.

Dr. Raghavendran is a Professor of Surgery in the Division of Acute Care Surgery. He received his medical education in India and immigrated to the United States in 1991, wherein he completed his Surgical Residency and subsequent fellowship in Surgical Critical Care. He has a long-standing interest in global health and established research collaborations between India and the University of Michigan medical school. He serves as one of the lead physicians for the University of Michigan India collaborative, a distinct platform under Global Reach. The collaborative extends across multiple sub-specialties and is currently working with many institutions across India. He has also been working on similar collaborative efforts in Ethiopia and Taiwan. Clinical Specialization:Dr. Raghavendran specializes in acute care surgery including trauma and care of the critically ill. Areas of publication include VTE, aspiration-induced lung injury, pulmonary surfactant biology and decompressive craniectomy for TBI. He has also been involved in the study of TBI and trauma systems in the global arena. Dr. Raghavendran is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Inflammation, Ogilvie Syndrome, Acute Respiratory Distress Syndrome (ARDS), Hernia Surgery, and Gallbladder Removal.

Dr. Donnele Daley is a faculty member within the Section of General Surgery at the University of Michigan.Dr. Daley graduated from Dartmouth College with a Bachelor of Engineering and Vassr College with a Bachelor of Arts in Physics and Mathematics. She graduated with General Honors and was elected into the Phi Beta Kappa Honor Society. She earned her medical degree from Penn State College of Medicine after which she was accepted into the General Surgery Residency program at New York University Medical Center. During her time at NYU, she spent two years in a postdoctoral research fellowship studying tumor immunology and the biology of pancreatic cancer, which fueled her interest in oncology research and cancer care. Upon finishing her General Surgery residency, she completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center in New York.Clinical Specialization:Dr. Daley is a practicing general and oncologic surgeon at the University of Michigan. Her practice encompasses gastrointestinal malignancies and she also specializes in gastric and peritoneal malignancies. Dr. Daley is trained and certified in Minimally Invasive and Robotic Surgery techniques. Dr. Daley is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Stomach Cancer, Pseudomyxoma Peritonei, Gastrointestinal Stromal Tumor, Gastrectomy, and Hernia Surgery.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bednar is board certified in Surgery and Complex General Surgical Oncology.

Dr. Uppal is a board-certified Gynecologic Oncologist and Division Chief for the Gynecology Oncology service at the University of Michigan. He is also the Director of Gynecologic Oncology Initiatives at the Michigan Oncology Quality Consortium (MOQC) - a statewide quality improvement network. Dr. Uppal received his medical degree from the All India Institute of Medical Sciences (AIIMS) in New Delhi, India. He completed his Obstetrics and Gynecology residency at Temple University Hospital in Philadelphia and a fellowship in Gynecology Oncology at the University of Wisconsin in Madison, Wisconsin. He joined the faculty of the University of Michigan in 2014. Dr. Uppal also holds a Master in Business Administration (MBA) from the University of the Michigan Stephen M. Ross School of Business.Dr. Uppal has been in clinical practice for over ten years and is involved in many Quality Improvement Projects in the Division of Gynecologic Oncology, nationally and across Michigan. Widely acknowledged as a thought leader in Gynecology Oncology and quality-of-care, he has authored over 75 peer-reviewed manuscripts and instituted changes in the health system to improve outcomes after surgery, reduce the cost of care and implemented patient-centered care delivery systems. Dr. Uppal is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy. Dr. Uppal is board certified in Gynecologic Oncology and Obstetrics & Gynecology.

Imad Shureiqi is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Shureiqi is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Pseudomyxoma Peritonei. Dr. Shureiqi is board certified in Medical Oncology.

Dr. Hansen is a graduate of the University of Michigan. She then completed her medical degree at the Kirksville College of Osteopathic Medicine and residency training at the University of Iowa Hospitals and Clinics. She completed her gynecologic oncology fellowship at MD Anderson Cancer Center. She joined the faculty as an assistant professor in 2018. She serves on national committees for both the Society of Gynecologic Oncology and NRG Oncology. She is the principal investigator for Gynecologic Oncology Group (GOG) and industry-sponsored clinical research trials available at the University of Michigan. Dr. Siedel is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor.

Oxana Crysler is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Crysler is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Crysler is board certified in Medical Oncology.

Dr. Jeffrey Smerage is a hematologist/oncologist specializing in breast cancer. He received both a medical and doctoral degree from the University of Florida and then went on to residency training at the University of Virginia. In 2004, after completing a fellowship in hematology and oncology at the University of Michigan, Dr. Smerage joined the faculty of the Department of Internal Medicine and began his practice in the Breast Care Center. Dr. Smerage is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is board certified in Medical Oncology and Clinical Informatics.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Dr. Veenstra earned her medical degree from Wayne State University in Detroit, Michigan and completed Internal Medicine internship and residency at the University of Michigan, where she also served as Chief Medical Resident. She completed her Medical Oncology fellowship training at the University of Pennsylvania, during which time she also earned a Masters in Health Policy Research. She joined the faculty at the University of Michigan in 2013.Dr. Veenstra’s research program focuses on the financial impacts of cancer diagnosis and treatment on patients and their families, the role of family in receipt of optimal cancer care, and issues facing cancer survivors. She currently holds a K07 Award from the National Cancer Institute to study the role of an engaged spouse or significant other in receipt of high quality surveillance care among survivors of colorectal cancer. Dr. Veenstra is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Gastroesophageal Junction Cancer. Dr. Veenstra is board certified in Medical Oncology.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Samantha Hendren is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Hendren is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Colostomy.

R Reynolds is an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Reynolds is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Hysterectomy, and Hernia Surgery.

Dr. Sahai is the Leader of the Gastrointestinal Medical Oncology Section and Associate Professor in the Division of Hematology-Oncology, Department of Internal Medicine. Dr. Sahai is also a member of the University of Michigan Rogel Cancer Center and Director of Tumor Response Assessment Core.Dr. Sahai attended medical school at the Government Medical College at Amritsar with the Baba Farid University of Health Science in India. He then completed his Masters in Clinical Epidemiology at Harvard School of Public Health followed by Internal Medicine residency training at University of Pittsburgh where he met his wife. He completed his fellowship in Hematology-Oncology at Northwestern University where he also served as the Chief Fellow. Subsequently, Dr. Sahai joined University of Michigan as Assistant Professor in Internal Medicine in 2013.Dr. Sahai is a clinician-scientist who sees patients within the Multidisciplinary Pancreatic and Liver Tumor programs. As a clinical investigator he is the Principal Investigator on several investigator-initiated clinical trials open across the U.S. His translational research program leverages the pancreaticobiliary cancer biobanks that he directs for the therapeutic investigation of novel compounds in patient-derived cell lines and xenograft models to help develop novel phase 1/2 investigator-initiated clinical trials. Dr. Sahai is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Zhen Zhou is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Hysterectomy, and Intrauterine Device Insertion. Dr. Zhou is board certified in Gynecologic Oncology and Obstetrics & Gynecology.

Melissa Brackmann, MD is an Assistant Professor of Gynecologic Oncology at the University of Michigan Medical School.Dr. Brackmann graduated from the University of Michigan with a degree in Cellular and Molecular Biology. She received her medical degree from Harvard Medical School in 2013 and completed residency in OBGYN at Michigan Medicine in 2017, followed by fellowship in Gynecologic Oncology at Michigan Medicine in 2020. She was faculty at the University of Utah from 2020 to 2023, where she served as the Associate Residency Program Director for the OBGYN residency program and Director of the Core Sub-Internship in Gynecologic Oncology. She returned to Michigan Medicine as an Assistant Professor in 2023.Dr. Brackmann's clinical interests include the surgical and medical management of gynecologic cancers, placenta accreta spectrum, minimally invasive surgical techniques and patient/family education.Dr. Brackmann's research interests include post-graduate medical education, surgical simulation and quality improvement.Outside of medicine, Dr. Brackmann enjoys spending time with friends and family and watching college football. Dr. Brackmann is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor. Dr. Brackmann is board certified in Obstetrics & Gynecology and Gynecologic Oncology.

Dr. Van Poznak received her medical degree from Cornell University Medical College and internal medicine residency training at The New York Hospital-Cornell Medical Center in New York City. Remaining in New York, she completed her fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) and started her oncology practice at MSKCC on the Breast Cancer Medicine Service. In 2006, Dr. Van Poznak joined the faculty of the University of Michigan where she is an active clinician in the U-M Rogel Cancer Center Breast Care Center. Her clinical and translational research is in breast cancer and its relationship to bone - including the diagnosis, treatment and prevention of osteoporosis in breast cancer patients, breast cancer biomarkers predicting site specific relapse, and bone metastases. Dr. Van Poznak is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Van Poznak is board certified in Medical Oncology.

Grace Chen is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, and Neuroendocrine Tumor. Dr. Chen is board certified in Medical Oncology and Internal Medicine.